Arkolith/Insider Trading/NXEN/Form 4

Goldfarb Robert I

Chief Operating OfficerNEXIEN BIOPHARMA, INC. (NXEN) · full profile →Form 4 · filed Aug 3, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 25, 2023Grant(A)250K——2.3M
Apr 1, 2023Grant(A)250K——2.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2020Grant(A)1.0M——1.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-23-010690) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML